Global Pharma Management

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter of 2008.

Net sales increased 3.7 percent to $901.6 million during the second quarter of 2008, compared to $869.3 million during the second quarter of 2007

Adjusted* diluted earnings per share during the second quarter of 2008 were $0.57 compared to $0.49 during the second quarter last year. GAAP second-quarter 2008 diluted earnings per share were $0.43 versus $0.20 for the same period last year. (Adjusted* measures exclude certain specified items as described later in this press release and attached schedules.

Christopher B. Begley, chairman and chief executive officer said, We made substantial progress advancing our business during the second quarter and remain on track to deliver another good year. The market-share gains we are capturing in both Specialty Injectable Pharmaceuticals and Medication Management Systems point to the value of our focus on strategic execution. With our solid year-to-date results and expectations for the remainder of the year, we are increasing our full-year sales guidance and narrowing our adjusted* EPS guidance to the top end of our projected range.